Both acarbose and voglibose were effective on improving glucose turnover in T2D patients who were taking insulin and metformin and blood glucose levels were not adequately controlled [125], indicating α-glucosidase inhibitors could be valuable supplements for T2D patients. This evidence concerns the gene INS and type 2 diabetes mellitus.